Skip to main content

FDA recall, , Moderate risk

Brahms B.R.A.H.M.S PlGF Plus KRYPTOR Diagnostic Test

The B.R.A.H.M.S PlGF Plus Kryptor test may show out-of-range quality control values, potentially leading to falsely elevated sFlt-1/PlGF ratio results.

What happened

Brahms GmbH is recalling the B.r.a.h.m.s PlGF Plus KRYPTOR, an in vitro diagnostic test for Placental Growth Factor, because customers have observed quality control values out of range at the lowest quality control level (QC Level 1) for the PIGF assay, which require troubleshooting steps to resolve. If Quality Controls are not performed according to the Instructions for Use, the underestimation of QC1 may go undetected and could contribute to falsely elevated sFlt-1/PlGF ratio results.

The recall began on March 12, 2026. Worldwide distribution includes US states such as NC, TX, MN, UT, NY, FL, OH, IL, CT, CA, GA, and other countries. The FDA added the recall to its Enforcement Report on April 8, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its UDI-DI and lot code are listed under that product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. B.R.A.H.M.S PlGF Plus KRYPTOR, Catalog Number: 859075N. in vitro diagnostic test for Placental Growth Factor

    UDI-DI
    • 04260157638976
    • 04260157632196
    Lot code
    • 40102
    • R78
    • R79
    • R80

Recall details

Company began the recall
Sold in

Worldwide distribution. US states: North Carolina, Texas, Minnesota, Utah, New York, Florida, Ohio, Illinois, Connecticut, California, Georgia. Other countries: Delaware, AT, Alabama, AU, BG, BR, California, CH, CZ, DK, EC, ET, ES, FR, GB, GR, HK, HU, Idaho, Illinois, IT, KW, KZ, LT, MK, ML, MX, NL, NO, Pennsylvania, PL, PT, RO, RS, SE, SI, TH, TU, TW, UA, ZA

Company
Brahms GmbHHennigsdorf, Germany
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98561
Recall number
Z-1795-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)